Article10.1007/s00280-015-2837-1
Phase I dose-finding and pharmacokinetic study of docetaxel and gefitinib in patients with advanced or metastatic non-small-cell lung cancer: evaluation of drug–drug interaction
Masanori Motonaga,Noboru Yamamoto,Yoshinori Makino,Reiko Ando-Makihara,Yuichiro Ohe,Mikihisa Takano+1 more-2015-08-01-Cancer Chemotherapy and Pharmacology
2
Chat with Paper
AI Agents for this Paper
No abstract available for this paper.
Keywords
DocetaxelGefitinibTolerabilityMedicinePharmacokineticsPharmacologyLung cancerToxicity
Chat
Click to start Chat